Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactation. [PDF]
Pan X, Rowland Yeo K.
europepmc +1 more source
Development and Characterization of pFluor50, a Fluorogenic-Based Kinetic Assay System for High-Throughput Inhibition Screening and Characterization of Time-Dependent Inhibition and Inhibition Type for Six Human CYPs. [PDF]
Shriwas P +8 more
europepmc +1 more source
Effect of CYP2D6 and ABCB1 polymorphisms on pharmacokinetics and efficacy of aripiprazole in pediatric tic disorders. [PDF]
Xin Y +11 more
europepmc +1 more source
A Comprehensive Analysis Examining the Role of Genetic Influences on Psychotropic Medication Response in Children. [PDF]
Singh J +3 more
europepmc +1 more source
Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination. [PDF]
Wongsurawat T +10 more
europepmc +1 more source
Impact of CYP2D6 genotype on fluoxetine exposure and treatment switch in adults and children/adolescents. [PDF]
Nordby KL, Faraj P, Molden E, Hole K.
europepmc +1 more source
Epigenetics in pharmacogenes encoding metabolizing enzymes of second-generation antipsychotics used in schizophrenia and its clinical implications. [PDF]
Alvarado AT +12 more
europepmc +1 more source
New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone : studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine [PDF]
Vollmar, Christian
core +1 more source
Mono-CYP CHO Model: A Recombinant Chinese Hamster Ovary Cell Platform for Investigating CYP-Specific Tamoxifen Metabolism. [PDF]
Schulz C, Stegen S, Jung F, Küpper JH.
europepmc +1 more source
Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes. [PDF]
Johansson I +6 more
europepmc +1 more source

